General procedures of infection control have been in use for decades. Among the various infection control procedures available in the market today, much attention is paid to the respiratory control aspect. While earlier, the demand for respiratory control devices was aided by the rising incidence of tuberculosis (TB), anthrax, and sudden acute respiratory syndrome (SARS), presently the market is propelled by the prevalence of avian flu (H5N1) and swine flu A (H1N1) viruses. Also known as respirators or surgical masks, respiratory control masks are intended to reduce the risk of infectious disease transmission from an infected to a non-infected person.
A report published by Persistence Market Research pegs the value of surgical and respirator mask market in Australia and New Zealand at US$134.9 million in 2014, which is anticipated to reach US$167.7 million by the end of 2021. If the figures hold true, the surgical and respirator masks market in these countries will expand at a moderate 3.3% CAGR during the 2015-2021 period.
Respiratory control masks have spurred much confusion in the healthcare industry with regard to determining the parameters to distinguish surgical masks from respirators. Despite the purpose of these medical implements being similar, they are used in distinct situations.
What are Respirators?
Respirators are typically designed to moderate a worker’s exposure to airborne infections or contaminants. They are available in different sizes and must be selected to fit the wearer’s face to provide an effective seal. Respirators offer protection to workers who work in close proximity to people with influenza-like symptoms. Respirators are, therefore, used by workers who are in occupations classified to have high-exposure risk to pandemic influenza.
What are Surgical Masks?
Surgical masks are medical implements that provide protection to medical professionals or patients against precipitations of blood or splashes of body fluids. These masks usually cover the mouth, nose, and chin of the wearer. They are known to trap large respiratory particles or specks of body fluids that may contain viruses or bacteria expelled by the wearer.
Factors Impelling Surgical and Respirator Masks Market Growth
The escalating number of surgical procedures, growing awareness regarding health and hygiene, and drive of product innovation are the key factors bolstering the global market for surgical and respirator masks. In the last couple of years, countries in the APAC region such as Australia and New Zealand have demonstrated an increasing demand for respirator and surgical masks, driven by the aforementioned factors. The report published by Persistence Market Research states that in Australia, the market for surgical and respirator masks, which stood at US$102.9 million in 2014, will reach US$106.2 million by the end of 2015. Likewise, the surgical and respirator masks market in New Zealand is likely to reach a valuation of US$38.2 million by 2021, rising from its market value of US$30.9 million in 2014.
Despite being a niche market in the healthcare industry, significant rise in its proceeds across various countries, especially those located in the APAC region, will significantly impel the growth of the global surgical and respirator masks market.